Group by:
Date |
Item TypeArticle
New cardiovascular biomarkers in patients with advanced cancer – a prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNP.
Anker, M.S., Lück, L.C., Khan, M.S., Porthun, J., Hadzibegovic, S., Lena, A., Wilkenshoff, U., Weinländer, P., Evertz, R., Totzeck, M., Mahabadi, A.A., Rassaf, T., Anker, S.D., Bullinger, L., Keller, U., Karakas, M., Landmesser, U., Butler, J. and von Haehling, S.
European Journal of Heart Failure
26 November 2024
(In Press)
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on pulmonary circulation & right ventricular function.
Ameri, P., Mercurio, V., Pollesello, P., Anker, M.S., Backs, Jo., Bayes-Genis, A., Borlaug, B.A., Burkhoff, D., Caravita, S., Chan, S.Y., de Man, F., Giannakoulas, G., González, A., Guazzi, M., Hassoun, P.M., Hemnes, A.R., Maack, C., Madden, B., Melenovsky, V., Müller, O.J., Papp, Z., Pullamsetti, S.S., Rainer, P.P., Redfield, M.M., Rich, S., Schiattarella, G.G., Skaara, H., Stellos, K., Tedford, R.J., Thum, T., Vachiery, J.L., van der Meer, P., Van Linthout, S., Pruszczyk, P., Seferovic, P., Coats, A.J.S., Metra, M., Rosano, G., Rosenkranz, S. and Tocchetti, C.G.
European Journal of Heart Failure 26
(4): 707-729.
April 2024
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
Anker, M.S., Potthoff, S.K., Lena, A., Porthun, J., Hadzibegovic, S., Evertz, R., Denecke, C., Fröhlich, A.K., Sonntag, F., Regitz-Zagrosek, V., Rosen, S.D., Lyon, A.R., Lüscher, T.F., Spertus, J.A., Anker, S.D., Karakas, M., Bullinger, L., Keller, U., Landmesser, U., Butler, J. and von Haehling, S.
European Journal of Heart Failure 25
(9): 1635-1647.
September 2023
The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė, J., Pudil, R., López-Fernández, T., Grapsa, J., Nihoyannopoulos, P., Bergler-Klein, J., Cohen-Solal, A., Farmakis, D., Tocchetti, C.G., von Haehling, S., Barberis, V., Flachskampf, F.A., Čeponienė, I., Haegler-Laube, E., Suter, T., Lapinskas, T., Prasad, S., de Boer, R.A., Wechalekar, K., Anker, M.S., Iakobishvili, Z., Buccarelli-Ducci, C., Schulz-Menger, J., Cosyns, B., Gaemperli, O., Belenkov, Y., Hulot, J.S., Galderisi, M., Lancellotti, P., Bax, J., Marwick, T.H., Chioncel, O., Jaarsma, T., Mullens, W., Piepoli, M., Thum, T., Heymans, S., Mueller, C., Moura, B., Ruschitzka, F., Zamorano, J.L., Rosano, G., Coats, A.J.S., Asteggiano, R., Seferovic, P., Edvardsen, T. and Lyon, A.R.
European Journal of Heart Failure 22
(9): 1504-1524.
September 2020
Long-term effects of Na(+)/Ca(2+) exchanger inhibition with ORM-11035 improves cardiac function and remodelling without lowering blood pressure in a model of heart failure with preserved ejection fraction.
Primessnig, U., Bracic, T., Levijoki, J., Otsomaa, L., Pollesello, P., Falcke, M., Pieske, B. and Heinzel, F.R.
European Journal of Heart Failure 21
(12): 1543-1552.
December 2019
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines.
Zamorano, J.L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D.J., Lip, G.Y.H., Lyon, A.R., Lopez Fernandez, T., Mohty, D., Piepoli, M.F., Tamargo, J., Torbicki, A., Suter, T.M., Zamorano, J.L., Aboyans, V., Achenbach, S., Agewall, S., Badimon, L., Barón-Esquivias, G., Baumgartner, H., Bax, J.J., Bueno, H., Carerj, S., Dean, V., Erol, C., Fitzsimons, D., Gaemperli, O., Kirchhof, P., Kolh, P., Lancellotti, P., Lip, G.Y.H., Nihoyannopoulos, P., Piepoli, M.F., Ponikowski, P., Roffi, M., Torbicki, A., Vaz Carneiro, A. and Windecker, S.
European Journal of Heart Failure 19
(1): 9-42.
January 2017
Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
Scherbakov, N., Bauer, M., Sandek, A., Szabo, T., Toepper, A., Jankowska, E.A., Springer, J., von Haehling, S., Anker, S.D., Lainscak, M., Engeli, S., Duengen, H.D. and Doehner, W.
European Journal of Heart Failure 17
(10): 1015-1021.
October 2015
Increased catabolic activity in adipose tissue of patients with chronic heart failure.
Szabo, T., Postrach, E., Mähler, A., Kung, T., Turhan, G., Von Haehling, S., Anker, S.D., Boschmann, M. and Doehner, W.
European Journal of Heart Failure 15
(10): 1131-1137.
October 2013
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.
van Rijsingen, I.A.W., Nannenberg, E.A., Arbustini, E., Elliott, P.M., Mogensen, J., Hermans-van Ast, J.F., van der Kooi, A.J., van Tintelen, J.P., van den Berg, M.P., Grasso, M., Serio, A., Jenkins, S., Rowland, C., Richard, P., Wilde, A.A.M., Perrot, A., Pankuweit, S., Zwinderman, A.H., Charron, P., Christiaans, I. and Pinto, Y.M.
European Journal of Heart Failure 15
(4): 376-384.
April 2013
Long-term benefits of immunoadsorption in beta(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel, M., Wallukat, G., Englert, A., Lehmkuhl, H.B., Knosalla, C. and Hetzer, R.
European Journal of Heart Failure 14
(12): 1374-1388.
December 2012
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
Waldmueller, S., Erdmann, J., Binner, P., Gelbrich, G., Pankuweit, S., Geier, C., Timmermann, B., Haremza, J., Perrot, A., Scheer, S., Wachter, R., Schulze-Waltrup, N., Dermintzoglou, A., Schoenberger, J., Zeh, W., Jurmann, B., Brodherr, T., Boergel, J., Farr, M., Milting, H., Blankenfeldt, W., Reinhardt, R., Oezcelik, C., Osterziel, K.J., Loeffler, M., Maisch, B., Regitz-Zagrosek, V., Schunkert, H. and Scheffold, T.
European Journal of Heart Failure 13
(11): 1185-1192.
November 2011
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
Duengen, H.D., Apostolovic, S., Inkrot, S., Tahirovic, E., Toepper, A., Mehrhof, F., Prettin, C., Putnikovic, B., Neskovic, A.N., Krotin, M., Sakac, D., Lainscak, M., Edelmann, F., Wachter, R., Rau, T., Eschenhagen, T., Doehner, W., Anker, S.D., Waagstein, F., Herrmann-Lingen, C., Gelbrich, G. and Dietz, R.
European Journal of Heart Failure 13
(6): 670-680.
June 2011
Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).
Stockburger, M., Gomez-Doblas, J.J., Lamas, G., Alzueta, J., Fernandez-Lozano, I., Cobo, E., Wiegand, U., Concha, J.F., Navarro, X., Navarro-Lopez, F. and de Teresa, E.
European Journal of Heart Failure 13
(6): 633-641.
June 2011
A pilot study of chronic, low-dose epoetin-β following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure.
Bergmann, M.W., Haufe, S., von Knobelsdorff-Brenkenhoff, F., Mehling, H., Wassmuth, R., Muench, I., Busjahn, A., Schulz-Menger, J., Jordan, J., Luft, F.C. and Dietz, R.
European Journal of Heart Failure 13
(5): 560-568.
May 2011
MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload.
el Azzouzi, H., van Oort, R.J., van der Nagel, R., Sluiter, W., Bergmann, M.W. and De Windt, L.J.
European Journal of Heart Failure 12
(1): 4-12.
January 2010
Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
Habedank, D., Kuehnle, Y., Elgeti, T., Dudenhausen, J.W., Haverkamp, W. and Dietz, R.
European Journal of Heart Failure 10
(11): 1149-1151.
November 2008
Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure.
Goehler, A., Conrads-Frank, A., Worrell, S.S., Geisler, B.P., Halpern, E.F., Dietz, R., Anker, S.D., Gazelle, G.S. and Siebert, U.
European Journal of Heart Failure 10
(10): 1026-1032.
October 2008
Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: Insights from cardiovascular magnetic resonance.
Schulz-Menger, J., Abdel-Aty, H., Rudolf, A., Elgeti, T., Messroghli, D., Utz, W., Boye, P., Bohl, S., Busjahn, A., Hamm, B. and Dietz, R.
European Journal of Heart Failure 10
(9): 850-854.
September 2008
Up-regulation of PPARgamma in myocardial infarction.
Fliegner, D., Westermann, D., Riad, A., Schubert, C., Becher, E., Fielitz, J., Tschope, C. and Regitz-Zagrosek, V.
European Journal of Heart Failure 10
(1): 30-38.
January 2008
Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes.
Clark, A.L., Knosalla, C., Birks, E., Loebe, M., Davos, C.H., Tsang, S., Negassa, A., Yacoub, M., Hetzer, R., Coats, A.J.S. and Anker, S.D.
European Journal of Heart Failure 9
(8): 839-844.
August 2007
Inhibition of prolyl 4-hydroxylase prevents left ventricular remodelling in rats with thoracic aortic banding.
Fielitz, J., Philipp, S., Herda, L.R., Schuch, E., Pilz, B., Schubert, C., Gunzler, V., Willenbrock, R. and Regitz-Zagrosek, V.
European Journal of Heart Failure 9
(4): 336-342.
April 2007
Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers.
Perrot, A., Sigusch, H.H., Naegele, H., Genschel, J., Lehmkuhl, H., Hetzer, R., Geier, C., Perez, L.V., Reinhard, D., Dietz, R., Osterziel, K.J. and Schmidt, H.H.
European Journal of Heart Failure 8
(5): 484-493.
August 2006
Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats.
Philipp, S., Juergensen, J.S., Fielitz, J., Bernhardt, W.M., Weidemann, A., Schiche, A., Pilz, B., Dietz, R., Regitz-Zagrosek, V., Eckardt, K.U. and Willenbrock, R.
European Journal of Heart Failure 8
: 347-354.
June 2006
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice.
McMurray, J., Cohen-Solal, A., Dietz, R., Eichhorn, E., Erhardt, L., Hobbs, F.D., Krum, H., Maggioni, A., McKelvie, R.S., Pina, I.L., Soler-Soler, J. and Swedberg, K.
European Journal of Heart Failure 7
: 710-721.
6 August 2005
Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure.
Krack, A., Richartz, B.M., Gastmann, A., Greim, K., Lotze, U., Anker, S.D. and Figulla, H.R.
European Journal of Heart Failure 6
: 403-407.
1 June 2004
Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction.
Philipp, S., Pagel, I., Hoehnel, K., Lutz, J., Buttgereit, J., Langenickel, T., Hamet, P., Dietz, R. and Willenbrock, R.
European Journal of Heart Failure 6
: 845-851.
1 January 2004
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.
McMurray, J., Cohen-Solal, A., Dietz, R., Eichhorn, E., Erhardt, L., Hobbs, R., Maggioni, A., Pina, I., Soler-Soler, J. and Swedberg, K.
European Journal of Heart Failure 3
: 495-502.
1 January 2001
A new model of congestive heart failure in the mouse due to chronic volume overload.
Scheuermann-Freestone, M., Freestone, N.S., Langenickel, T., Hoehnel, K., Dietz, R. and Willenbrock, R.
European Journal of Heart Failure 3
: 535-543.
1 January 2001
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe.
Cleland, J.G.F., Swedberg, K., Cohen-Solal, A., Cosin-Aguilar, J., Dietz, R., Follath, F., Gavazzi, A., Hobbs, R., Korewicki, J., Madeira, H.C., Preda, I., van Gilst, W.H., Widimsky, J., Mareev, V., Mason, J., Freemantle, N. and Eastaugh, J.
European Journal of Heart Failure 2
(2): 123-132.
June 2000
Review
Heart failure as a metabolic problem.
Anker, S.D. and Rauchhaus, M.
European Journal of Heart Failure 1
: 127-131.
1 June 1999
Letter
Indication for bromocriptine in peripartum cardiomyopathy: reply.
Habedank, D., Haverkamp, W., Dudenhausen, J.W. and Dietz, R.
European Journal of Heart Failure 11
(2): 223-224.
February 2009
Editorial
Is there a common genetic basis for all familial cardiomyopathies?
Perrot, A., Dietz, R. and Osterziel, K.J.
European Journal of Heart Failure 9
(1): 4-6.
January 2007
This list was generated on Thu Dec 26 20:30:01 2024 UTC.